NCT06386224 Internet-Delivered Pain Self-Management for Persons With Acute Recurrent and Chronic Pancreatitis Pain
| NCT ID | NCT06386224 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seattle Children's Hospital |
| Condition | Pancreatitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 280 participants |
| Start Date | 2024-05-01 |
| Primary Completion | 2028-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 280 participants in total. It began in 2024-05-01 with a primary completion date of 2028-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Severe and disabling abdominal pain is common in individuals with chronic pancreatitis. Although pain is associated with reduced quality of life and high economic and societal costs, there are limited effective options for pain management in this population. This study proposes an evidence-based psychological intervention approach using an internet-delivered pain self-management program to minimize the impact of pain and improve quality of life. The ultimate goal is to maximize the public health impact of the intervention with successful implementation and dissemination to pancreas clinics and to the community.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Willingness to use personal device with internet access (smart phone, computer, iPad) or to borrow a study iPad/hotspot * Diagnosis of CP defined as having obvious morphological features of CP (i.e., Cambridge 3-4 stage or the presence of pancreatic calcifications on CT scan and/or magnetic resonance cholangiopancreatography) * Diagnosis of RAP defined as having abdominal pain of a duration of \>=3 months, one episode of acute pancreatitis (AP), or RAP. * Having experienced moderate pain intensity (rated as 4 or higher on a 0-10 Numerical Rating Scale) in the last month from RAP or CP. Exclusion Criteria: * Undergoing treatment for cancer * Unable to read English well enough to complete questionnaires or read the study website * Currently experiencing suicidal ideation * Having received endoscopic therapy in the past 30 days * Currently receiving treatment from a psychologist (\> 4 sessions)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06386224 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pancreatitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06386224 currently recruiting?
Yes, NCT06386224 is actively recruiting participants. Contact the research team at tonya.palermo@seattlechildrens.org for enrollment information.
Where is the NCT06386224 trial being conducted?
This trial is being conducted at Seattle, United States.
Who is sponsoring the NCT06386224 clinical trial?
NCT06386224 is sponsored by Seattle Children's Hospital. The trial plans to enroll 280 participants.